Stay informed with the latest litigation news. Explore now

Solid Pharmaceutical Dosage Form Comprising An Hiv Protease Inhibitor Solid Dispersion - EP2258346B1

EP2258346

ABBOTT
Application Number
EP10181268A
Filing Date
Aug 23, 2004
Status
Revoked
Jul 10, 2020
Grant Date
Sep 27, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP2258346B1 was granted to Abbott on Sep 27, 2017 following the initial filing on Aug 23, 2004 under the application number EP10181268A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

F HOFFMANN LA ROCHEJun 26, 2018 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents